Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : Jazz Pharmaceuticals
Jazz Pharmaceuticals Showcases Epilepsy and Narcolepsy Research at AAN 2026
04/09/2026 | Companies
AAN 2026,
American Academy of Neurology,
behavioral symptoms,
cannabidiol,
clinical research,
cognitive function,
Dravet syndrome,
drug development,
DUET study,
EpiCom study,
Epidiolex,
epilepsy,
Jazz Pharmaceuticals,
Lennox-Gastaut syndrome,
medical conference,
narcolepsy,
neurological disorders,
neuroscience,
patient care,
Phase 3 trial,
rare diseases,
refractory epilepsy,
sleep disorders,
treatment outcomes,
tuberous sclerosis complex,
Xywav
Jazz Pharmaceuticals: Innovating Life-Changing Medicines & Sustainable Impact
07/11/2024 | Companies
20th Anniversary,
American Heart Association,
Biopharmaceutical Company,
Clinical Trials,
Community Impact,
Corporate Sustainability,
CSSI Governance,
Diversity in Clinical Trials,
Employee Engagement,
Employee Resource Teams,
Environmental Sustainability,
Executive Committee,
Innovative Treatments,
Jazz Pharmaceuticals,
Limited Treatment Options,
Neuroscience,
Oncology,
Patient-Centered Approach,
People-First Culture,
Philanthropy,
Purpose-Driven Culture,
Renewable Electricity,
Serious Illnesses,
Social Impact Strategy,
Stand Up To Cancer,
Sustainability Reporting,
Transformative Medicines,
Unmet Medical Needs,
Volunteering
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com